Clinical Trial

Multimodal Therapy Impact on Pancreatic Cancer Survival

Study acronym: MMTIPS
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this retrospective cohort study is to analyze change of treatment strategies affect the survival outcomes in patients of pancreatic cancer who received curative-intent treatment. The main question it aims to answer is: Hypothesis: Change of treatment strategies involving increased utility of neoadjuvant chemotherapy and aggressive surgical approaches of extended pancreatectomy improved the overall and progression free survival in the patients with pancreatic cancer. Participants received curative treatment for pancreatic cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-14.
Trial Details
NCT Number NCT06938906
Lead Sponsor National Cheng Kung University
Conditions Pancreatic Cancer, Neoadjuvant Chemotherapy, Pancreatectomy
Enrollment 405 participants
Start Date 2011-01-03
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-24